SCHEMBL26648144

SCHEMBL26648144

CC1(CN2CCNCC2)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCCCN5CCOCC5)c(S(=O)(=O)C(F)(F)F)c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)C1

nearest known ligand 0.72

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 15/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31450802 1.00 BCL2 (0.71) BCL2
SCHEMBL26647986 1.00 BCL2 (0.71) BCL2
SCHEMBL26648076 0.98 BCL2 (0.69) BCL2
SCHEMBL26648105 0.98 BCL2 (0.69) BCL2
SCHEMBL31450703 0.97 BCL2 (0.69) BCL2
SCHEMBL26648815 0.97 BCL2 (0.69) BCL2
SCHEMBL26648838 0.97 BCL2 (0.69) BCL2
SCHEMBL26647744 0.95 BCL2 (0.70) BCL2
SCHEMBL31450842 0.95 BCL2 (0.70) BCL2
SCHEMBL26648409 0.95 BCL2 (0.70) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023220425-A1 BCL-XL/BCL-2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-11-16 — — WO disclosed
Send feedback